Reaction
Pharyngeal Paraesthesia reporting signals
As of the last recalculation, Pharyngeal Paraesthesia appears in 1,540 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED (PRR 54.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 81 | 54.0 | 54.2 |
| Diphenhydramine | 169 | 40.5 | 40.6 |
| Diphenhydramine Hydrochloride | 330 | 34.0 | 34.0 |
| Infliximab-Dyyb | 70 | 33.9 | 33.9 |
| Hydrocortisone Sodium Succinate | 21 | 30.6 | 30.7 |
| Methylprednisolone | 249 | 28.9 | 28.9 |
| Desoximetasone | 39 | 28.4 | 28.4 |
| Methylprednisolone Sodium Succinate | 90 | 27.8 | 27.8 |
| Iohexol | 11 | 18.1 | 18.1 |
| Acetaminophen 500Mg | 280 | 17.9 | 17.9 |
| Acetaminophen Tablet Extended Release | 279 | 17.8 | 17.9 |
| Pain Reliever | 279 | 17.8 | 17.8 |
| Rituximab | 232 | 17.3 | 17.3 |
| Risedronate Sodium | 38 | 16.9 | 16.9 |
| Pegvaliase-Pqpz | 10 | 16.6 | 16.6 |
| Eptinezumab-Jjmr | 11 | 16.4 | 16.5 |
| Guanfacine | 9 | 15.5 | 15.6 |
| Omalizumab | 75 | 12.5 | 12.5 |
| Cetirizine Hydrochloride Allergy | 21 | 9.5 | 9.5 |
| Cetirizine Hydrochloride Tablets | 21 | 9.5 | 9.5 |
| Ocrelizumab | 40 | 8.9 | 8.9 |
| Lanreotide Acetate | 5 | 8.6 | 8.6 |
| Fremanezumab-Vfrm | 7 | 8.3 | 8.3 |
| Oxaliplatin | 40 | 7.5 | 7.5 |
| Nicotine | 16 | 5.4 | 5.4 |
| Inclisiran | 3 | 5.1 | 5.1 |
| Diroximel Fumarate | 4 | 4.5 | 4.5 |
| Glatiramer Acetate | 19 | 4.3 | 4.3 |
| Lifitegrast | 4 | 3.3 | 3.3 |